DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Hongshan Guo(Howard Hughes Medical Institute), Daniel A. Haber(Howard Hughes Medical Institute), David T. Miyamoto(Broad Institute), Joanna Vuille(Harvard University), Haley M. Pleskow(Harvard University), Alexander Meissner(Max Planck Institute for Molecular Genetics), Maoxuan Lin(Broad Institute), Andreas Gnirke(Broad Institute), Richard J. Lee(La Roche College), Chin‐Lee Wu(Massachusetts General Hospital), Yu Hou(China National Petroleum Corporation (China)), Brittany A. Reeves(Harvard University), Martin J. Aryee(Johns Hopkins University), Hunter C. Russell(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Emily M. Lachtara(Harvard University), Michael S. Lawrence(Broad Institute), Mehmet Toner(Center for Cancer Research), Ting C. Zhao(Zhejiang Chinese Medical University), Jason A. Efstathiou(Massachusetts General Hospital), Ayush T. Raman(National Institutes of Health)
Cited by 70
Related Papers
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
|Science|2009|9.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k